Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2196 of 6351
-
Balloons vs stents: new heart artery study could change treatment
Disease control Not yet recruitingThe goal of this clinical trial is to learn immediate and follow up results of percutaneous treatment of coronary bifurcation lesion using drug eluting balloons (DEB) only in patients with chronic coronary syndrome (CCS). Researchers will compare endovascular treatment using sole…
Sponsor: Avtandil M. Babunashvili • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New heart pump could offer lifeline for right heart failure patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and feasibility of the CorVad Percutaneous Ventricular Assist System (Device model: CorVad RS) in patients with right heart failure who continue to experience hemodynamic instability despite best medical therapy.
Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers with missing gene
Disease control Recruiting nowThe goal of this clinical study is to learn more about the study drug GS-2426, and how safe and tolerable it is in participants with advanced methylthioadenosine phosphorylase (MTAP)-deleted solid tumors. The primary objective of this study is to evaluate the safety and tolerabi…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new antibody tame ENPP1? a safety trial begins
Knowledge-focused OngoingThis is a Phase 1 single-blind, placebo-controlled, dose-escalation study designed to evaluate the safety of AD-NP1, a humanized monoclonal antibody targeting human ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1). The study aims to assess the maximum tolerated dose (MT…
Phase 1 • Sponsor: Arjun Deb, MD • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New study tests cheaper h. pylori treatment to beat antibiotic resistance
Disease control Not yet recruitingThis randomized controlled trial aims to compare the efficacy and safety of levofloxacin-based sequential therapy versus bismuth-based quadruple therapy for eradication of Helicobacter pylori infection in adult patients. Helicobacter pylori infection remains highly prevalent in d…
Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a gentler nasal tube replace the CPAP mask for kids with sleep apnea?
Disease control Not yet recruitingThis study is looking at two different treatments for obstructive sleep apnea (OSA) in children. OSA is a sleep condition where breathing repeatedly stops and starts during sleep, which can affect a child's health, behavior, learning, and quality of life. Children with moderate-…
Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Experimental CAR-T injection aims to tame autoimmune diseases
Disease control Not yet recruitingKSVCBD injection is an in vivo Chimeric Antigen Receptor T-Cell (CAR-T cell) therapy product. This single-arm, open-label, early exploratory clinical study is designed to evaluate the safety and preliminary efficacy of KSVCBD injection in patients with Autoimmune Diseases.
Early phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Local pharmacies join fight against stroke with quick heart check-ups for seniors
Diagnosis Not yet recruitingThis study evaluates the feasibility and fidelity of an opportunistic atrial fibrillation (AF) screening programme conducted in 38 community pharmacies in Seville (Spain), using the Kardias® 6-lead portable ECG device, coordinated with the emergency medical services centre Salud …
Sponsor: Centro de Emergencias Sanitarias 061 Andalucía • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Can a video call replace the Doctor's office for opioid addiction treatment?
Disease control CancelledThis study will compare in-person induction and maintenance dosing of sublingual buprenorphine to induction and maintenance dosing of sublingual buprenorphine through comprehensive telehealth sessions and telehealth medication for opioid use disorder (MOUD).
Phase 2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Your bathroom scale could soon warn you about heart failure
Diagnosis Not yet recruitingThis is a fully decentralized retrospective, non-interventional study evaluating the diagnostic performance of the Withings Heart Function Risk Notification (HFRN), a software-only medical device (SaMD)
Sponsor: Withings • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Eye exercises at home may help control wandering eyes when looking far away
Disease control Recruiting nowIntermittent Exotropia (IXT) is a common type of eye misalignment where one eye periodically turns outward, and control is typically much worse when looking at objects far away than close up. However, most currently available training programme are focused on near-viewing tasks. …
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common blood pressure drug tame a rare brain artery disorder?
Disease control Not yet recruitingThe aim of this pilot study is to assess the efficacy of amiloride in reducing wall enhancement in vertebrobasilar dolichoectasia(VBD) on high-resolution magnetic resonance vessel wall imaging(HR-VWI) via anti-inflammatory mechanisms, clarify the efficacy of amiloride in delaying…
Phase 2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Home workouts via smartphone could help tame type 2 diabetes
Disease control Recruiting nowThe intervention group received 12 weeks of continuous remote intervention combined with health education. The control group only received 12 weeks of continuous health education, and the content and frequency were the same as those of the management group. Both groups received i…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple supplement boost knee injection results for arthritis sufferers?
Symptom relief Not yet recruitingDegenerative knee joint diseases are characterized by chronic pain, inflammation, and functional impairment. In these conditions, mast cell density in the synovial membrane is increased, resulting in an excessive release of biological mediators involved in key mechanisms of neuro…
Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Immune cell levels may predict who will develop severe CMV after transplant
Knowledge-focused Recruiting nowCytomegalovirus (CMV) reactivation is a common and serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and the reconstitution of CMV-specific cell-mediated immunity (CMV-CMI) plays a key role in viral control. This prospective, exploratory …
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Wrist sensors and cameras could revolutionize rehab documentation
Knowledge-focused OngoingThis study looks at whether everyday rehabilitation therapy sessions can be recorded and measured in a more complete, objective way. Today, therapists usually document sessions by hand, and the notes can vary a lot from one therapist to another. This makes it hard to track exactl…
Sponsor: ETH Zurich • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Robots take on fragile pelvis fractures in the elderly
Symptom relief Not yet recruitingThis prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP…
Sponsor: Junbo Liang • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Massive VA study to settle debate: which blood thinner is safer for A-Fib?
Disease control Recruiting now* The trial will compare two anticoagulants ("blood thinners") that are currently used in the VA and are considered standard care to prevent strokes in patients with atrial fibrillation. The two most commonly-used anticoagulants will be compared: apixaban (Eliquis) and rivaroxaba…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New DNA reader aims to solve mystery of childhood epilepsy cases
Knowledge-focused Not yet recruitingThis study focuses on children with Developmental and Epileptic Encephalopathy (DEE), a severe form of epilepsy that often has a genetic origin. Currently, standard diagnostic tools-known as short-read genome sequencing-fail to provide a diagnosis for over 50% of affected patient…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New microscope could help surgeons remove all prostate cancer in one go
Diagnosis Not yet recruitingThis study will evaluate the use of intraoperative nonlinear microscopy (NLM) for surgical margin assessment during nerve-sparing radical prostatectomy in participants with prostate cancer.
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC